Paper37589736
Can nonsteroidal anti-inflammatory drugs (NSAIDs) be repurposed for fungal infection?
Babaei F and 4 others. Naunyn Schmiedebergs Arch Pharmacol, 2024. Cited by 12 papers, by iCite.
Cite this record
ConductScience Library. Can nonsteroidal anti-inflammatory drugs (NSAIDs) be repurposed for fungal infection? Papers, record 37589736. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37589736
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antifungal Agents | Major topic |
| Mycoses | Major topic |
| Humans | |
| Dinoprostone | |
| Anti-Inflammatory Agents, Non-Steroidal | |
| Aspirin |
Source PubMed
References87
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 19269752 | In vitro activity of terbinafine associated to amphotericin B, fluvastatin, rifampicin, metronidazole and ibuprofen against Pythium insidiosum. | Vet Microbiol | 2009 | https://conductscience.org/library/papers/19269752 | PubMed |
| 2 | 31399349 | Insights on the anticandidal activity of non-antifungal drugs. | J Mycol Med | 2019 | https://conductscience.org/library/papers/31399349 | PubMed |
| 3 | 20364371 | Paracoccidioides brasiliensis uses endogenous and exogenous arachidonic acid for PGE x production. | Mycopathologia | 2010 | https://conductscience.org/library/papers/20364371 | PubMed |
| 4 | 31850393 | Indifferent effect of nonsteroidal anti-inflammatory drugs (NSAIDs) combined with fluconazole against multidrug-resistant Candida auris. | Curr Med Mycol | 2019 | https://conductscience.org/library/papers/31850393 | PubMed |
| 5 | 26044360 | Involvement of electron and hydrogen transfers through redox metabolism on activity and toxicity of the nimesulide. | J Mol Model | 2015 | https://conductscience.org/library/papers/26044360 | PubMed |
| 6 | 24156913 | In vitro analysis of flufenamic acid activity against Candida albicans biofilms. | Int J Antimicrob Agents | 2014 | https://conductscience.org/library/papers/24156913 | PubMed |
| 7 | 27246782 | Repurposing of Aspirin and Ibuprofen as Candidate Anti-Cryptococcus Drugs. | Antimicrob Agents Chemother | 2016 | https://conductscience.org/library/papers/27246782 | PubMed |
| 8 | 36647379 | Candida albicans-enteric viral interactions-The prostaglandin E2 connection and host immune responses. | iScience | 2023 | https://conductscience.org/library/papers/36647379 | PubMed |
| 9 | 33203147 | Antifungal Drug Repurposing. | Antibiotics (Basel) | 2020 | https://conductscience.org/library/papers/33203147 | PubMed |
| 10 | 25737988 | Ibuprofen-mediated reversal of fluconazole resistance in clinical isolates of Candida. | J Clin Diagn Res | 2015 | https://conductscience.org/library/papers/25737988 | PubMed |
| 11 | 22510283 | Interaction of methylxanthines and gentamicin against Staphylococcus aureus and Pseudomonas aeruginosa: role of phosphodiesterase inhibition. | Acta Microbiol Immunol Hung | 2012 | https://conductscience.org/library/papers/22510283 | PubMed |
| 12 | 29735520 | Identification of Specific Components of the Eicosanoid Biosynthetic and Signaling Pathway Involved in Pathological Inflammation during Intra-abdominal Infection with Candida albicans and Staphylococcus aureus. | Infect Immun | 2018 | https://conductscience.org/library/papers/29735520 | PubMed |
| 13 | 35084852 | Fluconazole-COX Inhibitor Hybrids: A Dual-Acting Class of Antifungal Azoles. | J Med Chem | 2022 | https://conductscience.org/library/papers/35084852 | PubMed |
| 14 | 20819061 | Saccharomyces cerevisiae β-carbonic anhydrase: inhibition and activation studies. | Curr Pharm Des | 2010 | https://conductscience.org/library/papers/20819061 | PubMed |
| 15 | 28151949 | Identification of small molecules that disrupt vacuolar function in the pathogen Candida albicans. | PLoS One | 2017 | https://conductscience.org/library/papers/28151949 | PubMed |
| 16 | 30818309 | Therapeutic tools for oral candidiasis: Current and new antifungal drugs. | Med Oral Patol Oral Cir Bucal | 2019 | https://conductscience.org/library/papers/30818309 | PubMed |
| 17 | 23545303 | Candida albicans-Staphylococcus aureus polymicrobial peritonitis modulates host innate immunity. | Infect Immun | 2013 | https://conductscience.org/library/papers/23545303 | PubMed |
| 18 | 19416368 | Ibuprofen reverts antifungal resistance on Candida albicans showing overexpression of CDR genes. | FEMS Yeast Res | 2009 | https://conductscience.org/library/papers/19416368 | PubMed |
| 19 | 34103949 | Cotreatment with Aspirin and Azole Drugs Increases Sensitivity of Candida albicans in vitro. | Infect Drug Resist | 2021 | https://conductscience.org/library/papers/34103949 | PubMed |
| 20 | 29605543 | Anti-candidal activity of selected analgesic drugs used alone and in combination with fluconazole, itraconazole, voriconazole, posaconazole and isavuconazole. | J Mycol Med | 2018 | https://conductscience.org/library/papers/29605543 | PubMed |
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 12 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42622487 | Structural Modifications of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): New Horizons in Antimicrobial Drug Discovery. | Arch Pharm (Weinheim) | 2026 | https://conductscience.org/library/papers/42622487 | PubMed |
| 42406005 | Medicinal Chemistry Perspectives on Drug Repurposing: Innovative Approaches and Therapeutic Breakthrough. | Ther Innov Regul Sci | 2026 | https://conductscience.org/library/papers/42406005 | PubMed |
| 40426549 | Repurposing Mouthwashes: Antifungal and Antibiofilm Abilities of Commercially Available Mouthwashes Against Candida spp. | Antibiotics (Basel) | 2025 | https://conductscience.org/library/papers/40426549 | PubMed |
| 40135881 | Vesicle inhibition reduces Candida biofilm resistance. | Antimicrob Agents Chemother | 2025 | https://conductscience.org/library/papers/40135881 | PubMed |
| 39731595 | Exploring the anti-biofilm and gene regulatory effects of anti-inflammatory drugs on Candida albicans. | Naunyn Schmiedebergs Arch Pharmacol | 2025 | https://conductscience.org/library/papers/39731595 | PubMed |
| 39576268 | The mechanism research of itraconazole combined with aspirin in the treatment of vulvovaginal candidiasis through NF-κB signaling pathway. | Biomol Biomed | 2025 | https://conductscience.org/library/papers/39576268 | PubMed |
| 38136707 | Antifungal Biofilm Inhibitory Effects of Combinations of Diclofenac and Essential Oils. | Antibiotics (Basel) | 2023 | https://conductscience.org/library/papers/38136707 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/37589736
GET https://conductscience.org/api/papers/v1/37589736/references?page=2